Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability
PHASE1
The objective of the current study is to determine the relative bioavailabi...
Status
Completed
Location
1276.5.1 Boehringer Ingelheim Investigational Site
A Study in Healthy Humans to Assess the Relative Bioavailability of One Fixed-dose Combination Tablet Empagliflozin/Metformin Versus Jardiance® Tablet and Glifage® Tablet Administered Together
PHASE1
This trial is to establish bioequivalence of the fixed dose combination (FD...
Status
Completed
Location
Instituto de Ciências Farmacêuticas de Estudos e Pesquisas - ICF